Embedded Files
I help medical research charities and early-stage life sciences companies turn strong science into programs that funders, investors and partners back.
Oncology is my deepest expertise. The same judgement applies across life sciences.
Who I work with
Executive Directors and research leads at medical research charities, deciding where research investment will have the greatest impact
Founders and CSOs at early-stage biotech, diagnostics and health-tech companies, preparing for investment or a first clinical study
Research leaders building a major grant, consortium or clinical trials program
Boards that need senior scientific judgement at the table for a defined period
Three seats at the table
The scientist
The scientist
I took a paediatric leukaemia therapy from discovery through granted patents to an international compassionate-use trial. I read your data the way a reviewer will.
The builder
The builder
I led the design of CoACT, a $14M national clinical trials consortium of 70+ investigators across 30 institutions, and co-authored its funding model in the Medical Journal of Australia. Programs I have shaped have secured more than $120 million.
The funder
The funder
I've sat on the Great Ormond Street Hospital Children's Charity investment committee and review for the Swiss National Science Foundation and Blood Cancer UK. I know what a committee needs to see before it says yes.
How to work with me
Start with a decision
Start with a decision
A 90-minute Program Decision Session ($850 + GST) or a Funding Readiness Review ($2,250 + GST).
Go deeper
Go deeper
An independent Assessment or Translational Strategy, with fixed fees from $5,000 + GST.
Partner
Partner
Fractional Chief Scientific Advisor support: senior scientific leadership on a fixed-term basis, from $3,500 + GST per month.
Who we are
Apex Science is a specialist life sciences advisory practice based in Melbourne, with deep expertise in oncology.
The practice is led by Dr Jasper de Boer (PhD), a translational oncology scientist with more than two decades of experience across cancer research, clinical trials, and funding strategy in Australia and internationally.
His 57 Web of Science-indexed publications have been cited more than 2,400 times, including by 15 patents, and he has completed more than 50 verified peer reviews.
His work includes leading national multi-institutional research initiatives, shaping competitive funding programs, and supporting charities and early-stage life sciences companies across the oncology translation pathway.
Programs and partnerships developed through this work have secured more than $120 million in research and translational funding and contributed to the development of clinical trials and collaborative research networks.
Ready to move your program forward?
Ready to move your program forward?
Book a 30-minute call. We'll identify the decision in front of you and the fastest way to resolve it.
Page updated
Google Sites
Report abuse